Alimentiv and Summit collaborate to tackle liver disease NASH
Drug development programs will be driven forward by a collaboration between Alimentiv Inc. and Summit…
November 4, 2022 - 3 minutes
NASH
Strategic collaboration for drug to treat NASH, obesity and diabetes announced
A conditional and exclusive license agreement to develop and commercialize a drug to treat nonalcoholic…
September 16, 2022 - 4 minutes
Poxel publishes ALD studies
Two preclinical articles have been published in different journals for treatments being developed by French…
July 5, 2022 - 3 minutes
Is a Treatment for NASH Finally on the Horizon?
Despite several high-profile trial failures in the field, multiple players are getting close to the…
March 2, 2022 - 6 minutes
Sponsored
by Medpace
Infographic: The Key Role of Imaging in Clinical Trials
Medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound have…
January 26, 2021 - 2 minutes
Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon
Patients with the chronic liver disease NASH must now wait even longer for an approved…
May 13, 2020 - 4 minutes
NorthSea Therapeutics Raises €36M to Complete NASH Phase II Trial
The Dutch biotech NorthSea Therapeutics has raised a €36M ($40M) Series B round to fund…
January 8, 2020 - 2 minutes
Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial
Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M…
December 17, 2019 - 2 minutes
Treating Liver Diseases: Is This Preclinical Model the Solution?
Liver diseases are on the rise. Although many drug candidates are being developed, preclinical toxicity,…
December 4, 2019 - 6 minutes
Can This Cell Therapy Help Fight the NASH Epidemic?
Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD) and…
November 4, 2019 - 7 minutes
The First Approved NASH Therapy?
Genfit is poised to become the first company to get a treatment for NASH to…
July 30, 2019 - 6 minutes
Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M
The US-Chinese company Terns Pharmaceuticals will develop and commercialize Genfit’s phase III drug elafibranor for…
June 25, 2019 - 3 minutes
